ImmPACT-Bio Competitors and Similar CompaniesClear all
ImmPACT-Bio's competitors and similar companies include Gossamer Bio, Alpha Tau Medical, JW Therapeutics and Zymeworks.
 ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. | ||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2016 | Founding Date 2016 | Founding Date 2003 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations San Diego, US HQ Dublin 2, IE | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations CN HQ Suzhou Shi, CN | Locations Vancouver, CA HQ Seattle, US |
Employees | Employees 845% decrease | Employees 11820% increase | Employees 1041% increase | Employees 106 | Employees 45519% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 208 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 973.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $114.7m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $76.3m (FY, 2024) |
Net income | Net income N/A | Net income ($56.5m) (FY, 2024) | Net income N/A | Net income N/A | Net income ($122.7m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 18m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 26m (about 5 years ago) | Latest funding round $ 90m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 18m | Total funding raised $ 480m | Total funding raised $ 55m | Total funding raised $ 90m | Total funding raised $ 125.9m |
For sources of this data, please see the company profile
View Company Profiles
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View companyAlpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View company
JW Therapeutics
HQ
CN
Employees
106
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View company